53. Sjogren syndrome Clinical trials / Disease details

Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05016297 (ClinicalTrials.gov)	July 14, 2022	26/6/2021	Efficacy and Safety of Baricitinib in Sjogren's Syndrome	A Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients	Sjogren's Syndrome	Drug: Baricitinib;Drug: Hydroxychloroquine	Peking Union Medical College Hospital	Eli Lilly and Company	Recruiting	18 Years	75 Years	All	87	Phase 2	China
2	NCT04916756 (ClinicalTrials.gov)	January 16, 2020	1/6/2021	A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients	A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients	Sjogren's Syndrome	Drug: Baricitinib 2 MG	Peking Union Medical College Hospital	NULL	Completed	18 Years	N/A	All	11	Phase 1/Phase 2	China